NIMG-37. DELAYED PSEUDOPROGRESSION IN TWO PATIENTS UNDERGOING TTFIELDS TREATMENT FOR NEWLY DIAGNOSED GLIOBLASTOMA

PURPOSE: Tumor treatment fields (TTFields) are approved by the FDA for newly diagnosed as well as recurrent glioblastoma (GBM). TTFields have been shown to extend survival by 4.9 months in newly diagnosed GBM, and a landmark overall survival rate of 13% at 5 years. However, the specific effects rema...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Lowman, Allison, Hurrell, Sarah, Bobholz, Samuel, Connelly, Jennifer, Cochran, Elizabeth, Mueller, Wade, McGarry, Sean, Brehler, Michael, LaViolette, Peter
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2020
Schlagworte:
Neuroimaging
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651686/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.650
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge